持続性エリスロポエチン受容体活性化剤
1. Continuous erythropoietin receptor activatorContinuous erythropoietin receptor activator (CERA) is the generic term for drugs in a new class of third-generation erythropoietic-stimulating agents (ESAs). In the media, these agents are commonly referred to as 'EPO', short for erythropoietin. CERAs have an extended half-life and a mechanism of action that promotes increased stimulation of erythropoietin receptors compared with other ESAs. Under the trade name Mircera, Roche Pharmaceuticals received approval from the U.S.
Read “Continuous erythropoietin receptor activator” on English Wikipedia
Read “持続性エリスロポエチン受容体活性化剤” on Japanese Wikipedia
Read “Continuous erythropoietin receptor activator” on DBpedia
Read “Continuous erythropoietin receptor activator” on English Wikipedia
Read “持続性エリスロポエチン受容体活性化剤” on Japanese Wikipedia
Read “Continuous erythropoietin receptor activator” on DBpedia
Discussions
Log in to talk about this word.